再生中胚层注射系统

专为再生微球设计的输送系统。

九针皮内注射系统，专为常阻塞传统注射器的制剂（PDLLA、PLLA、PCL 和 CaHA）而指定。

Integrated Front View

What it is

Nine needles, one regulated feed.

Regenis is a cart-mounted delivery system for regenerative mesotherapy: a 13.3-inch touchscreen console, a 212 g handpiece, and a nine-needle array fed from a single negative-pressure line. Every needle draws from the same regulated supply.

Nine points, one application

The array covers the treatment area in one application, where manual injection delivers to one point at a time.

Specified for suspensions

Engineered for biostimulator suspensions — PDLLA, PLLA, PCL and CaHA — alongside conventional mesotherapy solutions.

Eight memory presets

Pressure and speed are stored per procedure and recalled from memory. Negative pressure is adjustable across ten levels, up to 90 kPa.

One regulated feed
Distribution chamber
Nine needles, one application

Schematic cross-section, not to scale. Redrawn from the manufacturer's sectional view, Hertz Biotechnology (Shenzhen).

了解更多

The failure

Suspensions block needles specified for solutions.

Biostimulators are suspensions of solid microspheres, not solutions. Where the hub narrows into the cannula, those microspheres can pack and bridge across the opening.

Partial occlusion

Flow falls without stopping, so the amount delivered stops matching the amount set.

Complete occlusion

Delivery stops mid-procedure and the needle has to be changed.

Scanning electron micrograph of an occluded needle hub — Scanning electron micrograph of an occluded needle tip. Manufacturer data, Hertz Biotechnology (Shenzhen).

了解更多

Why it happens

Solid particles, mixed by hand.

Biostimulator microspheres are solid and denser than their carrier, so they settle. How thoroughly a syringe is mixed by hand decides how evenly the dose is distributed, and that varies between operators and between passes.

X-ray of syringe contents after five mixing passes and after ten — X-ray of syringe contents after five mixing passes (left) and ten (right). Hand mixing does not distribute microspheres consistently. Manufacturer data, Hertz Biotechnology (Shenzhen).

Suspension, not solution

Particle size

Commonly cited at 20–50 µm. Published literature puts commercial biostimulator microparticles predominantly at 20–80 µm.

Operator-dependent

Mixing passes

The X-ray shows the same syringe format after five mixing passes and after ten. Distribution differs visibly between the two.

了解更多

What's different

Non-clogging geometry, held in a closed loop.

9needles

One feed, nine bores

The array is fed from a single regulated line, so every needle draws from the same chamber rather than from nine separate fills.

5signals

Sensed on every shot

Negative pressure, thrust force, speed, current and torque, sampled at millisecond intervals by sensors in the handpiece.

4×ARM + NPU

Decided on the device

A quad-core ARM CPU with a dedicated AI processing unit runs injection planning, clogging warning and risk analysis on a real-time operating system.

90kPa

Ten pressure levels

Stable negative-pressure control across ten adjustable levels, with rapid release between shots. Set per procedure and recalled from memory.

Perception

Negative pressure
Thrust force
Speed
Current
Torque

Control model — on-device

Quad-core ARM CPU with a dedicated AI processing unit. Injection planning, clogging warning and risk analysis run on a real-time operating system.

Actuation

Power
Rotation direction
Speed

Sensors report at millisecond intervals; drive output is adjusted while the injection is in progress.

了解更多

Protected design

The anti-clogging mechanism is patented.

The delivery path is the subject of a granted Chinese utility-model patent held by the manufacturer. These are the filing details; the certificate itself is a Chinese-language document and is not reproduced here.

Application number: 202421307575.3
Filed: 7 June 2024
Title: Microsphere injection anti-clogging device
Holder: Hertz Biotechnology (Shenzhen) Co., Ltd.

A patent is an intellectual-property right. It is not a marketing authorisation and does not describe device performance.

了解更多

Verifiable precision

The system says so when delivery is not nominal.

Nine needles share one regulated feed, so the treated area is covered in a single application. When the drive train meets resistance outside its expected envelope, the system raises a named alarm rather than continuing silently.

Manual — one point at a time

Regenis — nine points, one application

Distribution geometry only: where the needles sit, not how deep they go and not what follows.